Literature DB >> 12000061

Serum profiles of granulocyte-macrophage colony-stimulating factor and C-C chemokines in hypertensive patients with or without significant hyperlipidemia.

J T Parissis1, K F Venetsanou, M V Kalantzi, D D Mentzikof, S M Karas.   

Abstract

The present study investigates the differences in serum activity of granulocyte-macrophage colony-stimulating factor, macrophage chemoattractant protein-1, and macrophage inflammatory protein-1alpha between hypertensive patients with and without significant hyperlipidemia before receiving any medical treatment. The serum activity of the studied inflammatory factors is more elevated in hypertensive patients with significant hyperlipidemia and may be associated with atherosclerotic inflammatory process induced by the coexistence of 2 major cardiovascular risk factors.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 12000061     DOI： 10.1016/s0002-9149(99)00862-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  10 in total

Review 1.  Consolidated and emerging inflammatory markers in coronary artery disease.

Authors:  Valter Lubrano; Silvana Balzan
Journal:  World J Exp Med       Date:  2015-02-20

Review 2.  Current Status of Primary, Secondary, and Tertiary Prevention of Coronary Artery Disease.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2021-08-25

3.  Pathophysiology and Medical Treatment of Carotid Artery Stenosis.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2015-06-23

4.  Impact of macrophage inflammatory protein-1α deficiency on atherosclerotic lesion formation, hepatic steatosis, and adipose tissue expansion.

Authors:  Arion Kennedy; Marnie L Gruen; Dario A Gutierrez; Bonnie K Surmi; Jeb S Orr; Corey D Webb; Alyssa H Hasty
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

5.  Significant association between admission serum monocyte chemoattractant protein-1 and early changes in myocardial function in patients with first ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.

Authors:  Yong Zhu; Chengping Hu; Yu Du; Jianwei Zhang; Jinxing Liu; Hongya Han; Yingxin Zhao
Journal:  BMC Cardiovasc Disord       Date:  2019-05-10       Impact factor: 2.298

6.  Decreased Serum Monocyte Chemoattractant Protein-1 (MCP-1) Expression in Patients with Upper Gastrointestinal Bleeding.

Authors:  Guohui Xing; Lili Wang; Wei Li; Yanling Xu; Xia Shi; Guixing Xu; Jiajun Zhang
Journal:  Med Sci Monit       Date:  2019-03-10

7.  Factors Associated with RANTES Concentration in Cardiovascular Disease Patients.

Authors:  Olga M Koper-Lenkiewicz; Joanna Kamińska; Anna Lisowska; Anna Milewska; Tomasz Hirnle; Violetta Dymicka-Piekarska
Journal:  Biomed Res Int       Date:  2019-07-18       Impact factor: 3.411

8.  Association between plasma monocyte chemoattractant protein-1 concentration and cardiovascular disease mortality in middle-aged diabetic and nondiabetic individuals.

Authors:  Lorenzo Piemonti; Giliola Calori; Guido Lattuada; Alessia Mercalli; Francesca Ragogna; Maria Paola Garancini; Giacomo Ruotolo; Livio Luzi; Gianluca Perseghin
Journal:  Diabetes Care       Date:  2009-07-29       Impact factor: 17.152

Review 9.  The usefulness of circulating adipokine levels for the assessment of obesity-related health problems.

Authors:  Hidekuni Inadera
Journal:  Int J Med Sci       Date:  2008-08-29       Impact factor: 3.738

10.  Serum levels of the MCP-1 chemokine in patients with ischemic stroke and myocardial infarction.

Authors:  A Arakelyan; J Petrkova; Z Hermanova; A Boyajyan; J Lukl; M Petrek
Journal:  Mediators Inflamm       Date:  2005-08-14       Impact factor: 4.711
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.